HBY Factory supply ranitidine raw material CAS 66357-35-5 Ranitidine HCl powder
Product Name
HBY Factory supply ranitidine raw material CAS 66357-35-5 Ranitidine HCl powder
Appearance
white or light yellow Crystalline powder
CAS NO
66357-35-5
MF
C13H23ClN4O3S
Molecule Weight
350.87
Shelf Life
2 years
Storage
keep in cool dry place
What is Ranitidine HCL?
Ranitidine is a histamine H2 receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). Ranitidine is also used alongside fexoamines for the treatment of skin conditions such as hives. Ranitidine is also known to give false positives for methamphetamine on drug tests.
Function of Ranitidine HCL
1.For the treatment oe, a large number of ranitidine may inhibit gastric acid secretion, symptoms. Also used for general anesthesia or coma patients after major surgery and weakness to prevent acid reflux with inhalation pneumonia.
2.Suitable for postoperative gastric ulcer, duodenal ulcer, ulcer, reflux esophagitis, etc.
3.Clinical findings and ranitidine in the Treatment of Recurrent Aphthous ulcer and other diseases also have good effect.
Application of Ranitidine HCL
Recurrent oral ulcer Use of ranitidine in the treatment of recurrent aphthous ulcer, pain within 1-2 days 3-5 days to heal, the total effective rate of 100%, and metronidazole in the treatment of control group is 85%, there are significant differences. Usage: oral ranitidine 150 mg per time, 2 times per day, or ranitidine Ding Yan into fine powder and apply directly on the ulcer surface, 3 times per day until the symptoms disappear.
Mumps Application of ranitidine in treatment of patients with mumps, the effect is significant, significantly better than the control group treated with Morpholine croak. Usage: oral ranitidine, 15 mg/kg ·, 2 suits, for 3 days in a row. If the heat is too high, and with physical cooling.
Ulcerative colitis Ranitidine was used to treat patients with ulcerative colitis, the total effective rate of 95%. Usage: oral ranitidine 150 mg per time, daily morning and evening 1, taken in March.
Verrucous gastritis Application of ranitidine in the treatment of Verrucous gastritis and achieve significant efficacy in one week, the total effective rate of 87%, while the control group only 33%, very significant differences between the two groups. Usage: oral ranitidine 150 mg per time, morning and evening, 1 times, warm water delivery service, for 1 course of 5 weeks.
